Science
Mechanism of Action
This tripeptide mimics the action of specific cytokines by selectively binding to TGF beta receptor 2 located on fibroblast membranes. This interaction initiates a signaling cascade, activating Smad proteins that translocate to the nucleus to boost the genetic expression of key extracellular matrix genes, particularly those responsible for type I collagen and hyaluronic acid synthesis. Furthermore, Palmitoyl Tripeptide-28 actively inhibits metalloproteinases (MMPs), enzymes that typically degrade collagen, thereby preserving skin integrity. It also enhances cellular adhesion through integrin stimulation and promotes the synthesis of protease inhibitors, collectively safeguarding existing collagen and elastin levels.
Research
Clinical Evidence
Insufficient-data confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Palmitoyl Tripeptide-28 demonstrates good stability. For optimal preservation, store in a cool, dry place between 2-8°C and protect from light. For long-term storage, maintaining temperatures between -20°C and -15°C is recommended.
Safety
Safety Profile
Palmitoyl Tripeptide-28 was listed in the FDA's Voluntary Cosmetic Registration Program (VCRP) in 2012, indicating its use in cosmetic products. The CIR Expert Panel's 2013 review of 'palmitoyl oligopeptides,' a group including this ingredient, was tabled due to insufficient terminology for adequate evaluation. However, general palmitoyl tripeptides are noted for their low irritation potential, and no specific skin or eye irritation has been reported for Palmitoyl Tripeptide-28 itself.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Palmitoyl Tripeptide-28 exhibits a promising scientific mechanism for enhancing skin structure and youthfulness; however, a definitive safety assessment from regulatory bodies and specific clinical efficacy studies are required for a confident recommendation in precision skincare formulations.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources